Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Pharmather Hldgs Ltd (PHRM.CN)

Pharmather Hldgs Ltd (PHRM.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 19,281
  • Shares Outstanding, K 68,860
  • Annual Sales, $ 0 K
  • Annual Income, $ 2,664 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 35.60
  • Price/Book 3.95
Trade PHRM.CN with:
  • Price/Earnings ttm 7.00
  • Earnings Per Share ttm 0.04
  • Most Recent Earnings -0.01 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.250 unch
on 01/21/22
0.405 -38.27%
on 01/07/22
-0.040 (-13.79%)
since 12/21/21
3-Month
0.250 unch
on 01/21/22
0.590 -57.63%
on 10/22/21
-0.340 (-57.63%)
since 10/21/21
52-Week
0.185 +35.14%
on 04/08/21
1.240 -79.84%
on 07/26/21
-0.225 (-47.37%)
since 01/21/21

Most Recent Stories

More News
Stocks in play: PharmaTher Inc

Is pleased to provide an update on the Company’s psilocybin pharmaceutical development programs. The ...

PHRM.CN : 0.260 (-7.14%)
PharmaTher Announces FDA Approval of Investigational New Drug (IND) Application for Ketamine to Treat ALS

TORONTO, Jan. 12, 2022 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a company focused on the...

PHRRF : 0.2060 (-6.36%)
PHRM.CN : 0.260 (-7.14%)
PharmaTher Provides Update on Product Pipeline and Expected Milestones for 2022

Focused on becoming a leader in the development and commercialization of specialty ketamine prescription-based products Expected milestones for 2022...

PHRM.CN : 0.260 (-7.14%)
PHRRF : 0.2060 (-6.36%)
PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening Global Patent Portfolio

TORONTO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage...

PHRRF : 0.2060 (-6.36%)
PHRM.CN : 0.260 (-7.14%)
PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat Rare Neurological Disorder Status Epilepticus

Adds to PharmaTher’s existing FDA orphan drug portfolio with amyotrophic lateral sclerosis and complex regional pain syndromeStrengthens commitment to...

PHRRF : 0.2060 (-6.36%)
PHRM.CN : 0.260 (-7.14%)
PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch

Delivering psilocybin via microneedle patch unlocks potential for desired dosage forms and pharmacokinetic profiles for improved safety and...

PHRRF : 0.2060 (-6.36%)
PHRM.CN : 0.260 (-7.14%)
PharmaTher Enters into Research Collaboration Agreement with Revive Therapeutics for Development of Psilocybin Microneedle Patch

Focusing on partnership model for MicroDose-MN™ and MacroDose-MN™ patches to deliver psychedelics.Creating value and intellectual property protection for...

PHRRF : 0.2060 (-6.36%)
PHRM.CN : 0.260 (-7.14%)
RVVTF : 0.2450 (-3.16%)
RVV.CN : 0.305 (-4.69%)
PharmaTher Provides Research Update on Microneedle Patch Delivery Technologies for Psychedelics

Completing IND-enabling studies with novel microneedle patch for ketamine, psilocybin, MDMA, LSD, and DMT.Expanding research in evaluating ibogaine and...

PHRRF : 0.2060 (-6.36%)
PHRM.CN : 0.260 (-7.14%)
PharmaTher Provides Business Update and Releases Financial Results for the First Quarter of Fiscal 2022

TORONTO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage...

PHRRF : 0.2060 (-6.36%)
PHRM.CN : 0.260 (-7.14%)
World Leading Drug Delivery Researcher Professor Ryan Donnelly Joins PharmaTher as Scientific and Technical Advisor

Focus on expanding the delivery of controlled-substances in a microneedle patch.Evaluating potential uses of a microneedle patch for infectious...

PHRRF : 0.2060 (-6.36%)
PHRM.CN : 0.260 (-7.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 0.333
2nd Resistance Point 0.317
1st Resistance Point 0.298
Last Price 0.260
1st Support Level 0.263
2nd Support Level 0.247
3rd Support Level 0.228

See More

52-Week High 1.240
Fibonacci 61.8% 0.837
Fibonacci 50% 0.712
Fibonacci 38.2% 0.588
Last Price 0.260
52-Week Low 0.185

See More

Business Summary

PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar